Natco Pharma receives USFDA tentative approval for generic Lynparza tablets
Natco Pharma received USFDA tentative approval for generic Olaparib tablets, a version of AstraZeneca’s Lynparza. Natco will manufacture, Alembic will distribute in the US. By CNBC-TV18 July 18, 2026, 6:11:53 PM IST (Published) 1 Min Read Natco Pharma Ltd. has received tentative approval from the US Food and Drug Administration (USFDA) for Olaparib Tablets in…
